Bhatia V, Chandel A, Minhas Y, Kushawaha S
Neurol Sci. 2025; .
PMID: 39893357
DOI: 10.1007/s10072-025-08023-y.
Mehta R, Keith C, Teixeira C, Worhunsky P, Phelps H, Ward M
Cereb Cortex. 2024; 34(12).
PMID: 39714256
PMC: 11664631.
DOI: 10.1093/cercor/bhae475.
Bonomi C, Motta C, Di Donna M, Poli M, Nuccetelli M, Bernardini S
Alzheimers Res Ther. 2024; 16(1):248.
PMID: 39550595
PMC: 11568584.
DOI: 10.1186/s13195-024-01617-2.
Wuestefeld A, Binette A, van Westen D, Strandberg O, Stomrud E, Mattsson-Carlgren N
Alzheimers Res Ther. 2024; 16(1):204.
PMID: 39285454
PMC: 11403779.
DOI: 10.1186/s13195-024-01571-z.
Cho J, Yoon C, Shin J, Seo H, Kim W, Na H
Sci Rep. 2024; 14(1):20429.
PMID: 39227668
PMC: 11372067.
DOI: 10.1038/s41598-024-71402-6.
Diverging Relationships among Amyloid, Tau, and Brain Atrophy in Early-Onset and Late-Onset Alzheimer's Disease.
Na H, Shin J, Kim S, Seo S, Kim W, Kang J
Yonsei Med J. 2024; 65(8):434-447.
PMID: 39048319
PMC: 11284308.
DOI: 10.3349/ymj.2023.0308.
Novel early-onset Alzheimer-associated genes influence risk through dysregulation of glutamate, immune activation, and intracell signaling pathways.
Cruchaga C, Bradley J, Western D, Wang C, Lucio Da Fonseca E, Neupane A
Res Sq. 2024; .
PMID: 38883718
PMC: 11177996.
DOI: 10.21203/rs.3.rs-4480585/v1.
Disease progression modelling reveals heterogeneity in trajectories of Lewy-type α-synuclein pathology.
Mastenbroek S, Vogel J, Collij L, Serrano G, Tremblay C, Young A
Nat Commun. 2024; 15(1):5133.
PMID: 38879548
PMC: 11180185.
DOI: 10.1038/s41467-024-49402-x.
Medial temporal lobe atrophy patterns in early- versus late-onset amnestic Alzheimer's disease.
Wuestefeld A, Binette A, van Westen D, Strandberg O, Stomrud E, Mattsson-Carlgren N
bioRxiv. 2024; .
PMID: 38826333
PMC: 11142072.
DOI: 10.1101/2024.05.21.594976.
Molecular neuroimaging in dominantly inherited versus sporadic early-onset Alzheimer's disease.
Iaccarino L, Llibre-Guerra J, McDade E, Edwards L, Gordon B, Benzinger T
Brain Commun. 2024; 6(3):fcae159.
PMID: 38784820
PMC: 11114609.
DOI: 10.1093/braincomms/fcae159.
Longitudinal associations of apathy and regional tau in mild cognitive impairment and dementia: Findings from the Alzheimer's Disease Neuroimaging Initiative.
Premnath P, Locascio J, Mimmack K, Gonzalez C, Properzi M, Udeogu O
Alzheimers Dement (N Y). 2024; 10(1):e12442.
PMID: 38356477
PMC: 10865481.
DOI: 10.1002/trc2.12442.
The Potential of a Stratified Approach to Drug Repurposing in Alzheimer's Disease.
Anderson C, Bucholc M, McClean P, Zhang S
Biomolecules. 2024; 14(1).
PMID: 38275752
PMC: 10813465.
DOI: 10.3390/biom14010011.
Longitudinal clinical, cognitive and biomarker profiles in dominantly inherited versus sporadic early-onset Alzheimer's disease.
Llibre-Guerra J, Iaccarino L, Coble D, Edwards L, Li Y, McDade E
Brain Commun. 2023; 5(6):fcad280.
PMID: 37942088
PMC: 10629466.
DOI: 10.1093/braincomms/fcad280.
Human isogenic cells of the neurovascular unit exert transcriptomic cell type-specific effects on a blood-brain barrier in vitro model of late-onset Alzheimer disease.
Haferkamp U, Hartmann C, Abid C, Brachner A, Hochner A, Gerhartl A
Fluids Barriers CNS. 2023; 20(1):78.
PMID: 37907966
PMC: 10617216.
DOI: 10.1186/s12987-023-00471-y.
Amyloid and tau-PET in early-onset AD: Baseline data from the Longitudinal Early-onset Alzheimer's Disease Study (LEADS).
Cho H, Mundada N, Apostolova L, Carrillo M, Shankar R, Amuiri A
Alzheimers Dement. 2023; 19 Suppl 9:S98-S114.
PMID: 37690109
PMC: 10807231.
DOI: 10.1002/alz.13453.
Neuropathology of the Alzheimer's continuum: an update.
Jellinger K
Free Neuropathol. 2023; 1.
PMID: 37283686
PMC: 10209886.
DOI: 10.17879/freeneuropathology-2020-3050.
Data-driven neuropathological staging and subtyping of TDP-43 proteinopathies.
Young A, Vogel J, Robinson J, McMillan C, Ossenkoppele R, Wolk D
Brain. 2023; 146(7):2975-2988.
PMID: 37150879
PMC: 10317181.
DOI: 10.1093/brain/awad145.
A global view of the genetic basis of Alzheimer disease.
Reitz C, Pericak-Vance M, Foroud T, Mayeux R
Nat Rev Neurol. 2023; 19(5):261-277.
PMID: 37024647
PMC: 10686263.
DOI: 10.1038/s41582-023-00789-z.
Influence of Host Age on Intracranial AAV9 TauP301L Induced Tauopathy.
Tetlow A, Jackman B, Alhadidy M, Perumal V, Morgan D, Gordon M
J Alzheimers Dis. 2023; 93(1):365-378.
PMID: 36970910
PMC: 10540220.
DOI: 10.3233/JAD-221276.
Data-driven neuropathological staging and subtyping of TDP-43 proteinopathies.
Young A, Vogel J, Robinson J, McMillan C, Ossenkoppele R, Wolk D
medRxiv. 2023; .
PMID: 36778217
PMC: 9915837.
DOI: 10.1101/2023.01.31.23285242.